Understanding Retatrutide: Potential New Weight Loss Medication Under Development

As the interest in GLP-1 weight loss medications like Wegovy and Zepbound grows, it’s essential to recognize that they may not work for everyone. Approximately 17% of individuals taking these medications are classified as “non-responders.” In search of alternatives, some people are turning their attention to retatrutide, a promising new treatment that is not yet approved by the Food and Drug Administration (FDA).

What is Retatrutide?

Retatrutide is a triple-agonist medication, meaning it targets three receptors in the body—glucagon-like peptide-1 (GLP-1), gastric inhibitory polypeptide (GIP), and glucagon (GCG). This contrasts with Wegovy, which acts on only one receptor, and Zepbound, which influences two. The expectation is that targeting more receptors may lead to enhanced effectiveness. According to Dr. Mir Ali, medical director of the MemorialCare Surgical Weight Loss Center, this medication has generated significant excitement within the medical community due to its potential for weight loss.

The current phase-three clinical trials indicate that retatrutide could be among the most effective weight loss medications available. Data from these clinical trials suggest that participants experienced an average weight loss of 28.7% over 68 weeks while using the highest dose of retatrutide. This level of effectiveness outpaces that of other medications like tirzepatide, which showed a 15% to 22.5% weight loss, and semaglutide, leading to a 10% to 15% reduction in body weight over similar timeframes.

How Are People Accessing Retatrutide?

Despite its unapproved status, reports indicate that some individuals have been able to locate retatrutide through online pharmacies. The rise in unauthorized sales has prompted the FDA to issue a press release, reiterating the illegality of selling retatrutide as well as cagrilintide, another unapproved weight loss solution.

The FDA specifically notes that neither medication has been found to be safe and effective for any health conditions, making their sales and distribution in compounding pharmacies a violation of federal law. As the agency continues to monitor these situations, it has taken action against companies distributing these unapproved medications.

The Advice from Healthcare Professionals

Given the risks associated with using retatrutide at this stage, experts strongly advise against it unless under clinical trial supervision. Dr. Richard Siegel, an endocrinologist at Tufts Medicine, underscores the importance of FDA approval, which involves rigorous safety assessments of medications including their potential side effects.

That said, compounding pharmacies introduce another layer of uncertainty. While they may create alternatives during shortages of approved drugs, the legality of selling compounded medications like retatrutide becomes gray once the shortage ends. Such medications are not subject to the same stringent oversight, raising concerns about their safety and effectiveness, as highlighted by Dr. Siegel.

Dr. Ali emphasizes the importance of working with healthcare providers if one is considering using compounded drugs, stressing the potential danger of acquiring ineffective or unsafe medications. He reiterates that FDA-approved medications have undergone extensive study, making them a more predictable and safer choice.

What to Consider if You’re Not Responding to Current Medications

For those deemed non-responders to current treatments, Dr. Siegel advises that there are various options available for weight management. If a particular medication has not yielded the desired outcomes, consulting with a healthcare provider about alternative options is advisable. In cases where standard medical advice has not been fruitful, seeking out a specialist in obesity medicine can provide insights into additional treatment strategies.

Weight management strategies should encompass more than just medication. Dr. Siegel points out that combining pharmaceutical options with lifestyle modifications—such as nutrition management and a structured exercise plan that incorporates both aerobic and resistance training—is key to long-term success. Each of these components plays a role in achieving weight loss goals.

If a weight loss medication seems necessary, exploring options with a healthcare provider who specializes in obesity management can facilitate a tailored approach to treatment. It’s important to note that these medications are often intended for individuals with significant weight loss needs, potentially requiring long-term use.

Utilizing FDA-approved medications is critical for safety, as they possess well-studied effects and side effects. As the landscape of weight loss treatments evolves, staying informed and cautious is essential for navigating these emerging options.

Related:

• On a GLP-1? This Is the Workout Plan That Helps You Keep Muscle
• How GLP-1s Are Quietly Reshaping Gym Culture
• The Ultimate Grocery List for GLP-1 Users, According to a Dietitian

Get more of SELF’s great service journalism delivered right to your inbox.